CG Oncology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-	-67.8	-43.79	-18.38
Depreciation & Amortization	-	0.03	0.03	0.01
Share-Based Compensation	-	1.53	0.68	1.11
Other Operating Activities	-	1.37	4.93	-1.94
Operating Cash Flow	-	-45.68	-29.8	-13.65
Capital Expenditures	-	0	-0.01	-0.1
Change in Investments	-	-121.2	-55.34	0
Investing Cash Flow	-	-121.2	-55.35	-0.1
Share Issuance / Repurchase	-	2.08	0.17	0.25
Debt Issued / Paid	-	-16.29	0	15.2
Other Financing Activities	-	101.21	119.53	-
Financing Cash Flow	-	87	119.69	15.45
Net Cash Flow	-	-79.88	34.54	1.7
Free Cash Flow	-	-45.68	-29.82	-13.75
Free Cash Flow Margin	-	-22391.67%	-15611.52%	-132.76%
Free Cash Flow Per Share	-	-10.55	-7.97	-3.77

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).